Moderna to showcase broad infectious disease vaccine research across COVID-19, RSV, influenza, mpox, and more at ESCMID 2025 global congress

Moderna, Inc. announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), cytomegalovirus (CMV), norovirus, and mpox, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Vienna, Austria, from April 11-15, 2025.

Moderna will present twelve scientific presentations at the ESCMID 2025 Global Congress, including three oral presentations, one e-poster presentation, and eight poster presentations, highlighting the breadth of its research in respiratory and emerging infectious diseases.

COVID-19

• Immunogenicity of JN.1- and KP.2-encoding mRNA COVID-19 vaccines against JN.1 SARS-CoV-2 sublineages in adult participants – Oral Presentation
  Presenter: Frances Priddy
  Session: Advances in vaccine effectiveness for viral respiratory infections
  Date: April 12 | Time & Location: 11:00 (Hall 9)
• Relative vaccine efficacy of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine versus mRNA-1273: subgroup analyses - Oral Presentation
  Presenter: Spyros Chalkias
  Session: Vaccines and prophylaxis against respiratory viral infections
  Date: April 13 | Time & Location: 11:00 (Hall 9)
• Clinical evaluation of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine - Poster Presentation
  Presenter: Spyros Chalkias
  Session: COVID-19
  Date: April 12 | Time & Location: 12:00 (Poster Hall)
• Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants aged ≥12 years - Poster Presentation
  Presenter: Christina Grassi
  Session: COVID-19
  Date: April 12 | Time & Location: 12:00 (Poster Hall)

RSV

• Six-month Immunogenicity of mRNA-1345 RSV Vaccine in Adults Aged ≥60 Years - E-Poster Presentation
  Presenter: Mihir Desai
  Session: On the frontiers of vaccine-driven prevention
  Date: April 12 | Time & Location: 08:30 (Arena 1)
• Safety and immunogenicity of mRNA-1345 revaccination at 24 months in adults ≥60 years - Poster Presentation
  Presenter: Mihir Desai
  Session: Clinical Trials
  Date: April 15 | Time & Location: 12:00 (Poster Hall)
• Burden of chronic medical conditions that are risk factors for severe RSV among adults aged 18-59 years in the United States - Poster Presentation
  Presenter: Clarisse Demont
  Session: Influenza and respiratory viruses
  Date: April 12 | Time & Location: 12:00 (Poster Hall)
• Association of virology swab positivity in adults aged ≥40 years with Computerized Medical Record Reported Acute Respiratory Infection (ARI) Subgroups: Observational Study of ARI (ObservatARI) - Poster Presentation
  Presenter: Simon De Lusignan
  Session: Influenza and respiratory viruses
  Date: April 12 | Time & Location: 12:00 (Poster Hall)

Mpox

• Safety and immunogenicity of mRNA mpox vaccine candidate mRNA-1769: Interim analysis results from a Phase 1/2 Trial - Oral Presentation
  Presenter: Hiwot Hiruy
  Session: Novel vaccines in clinical development
  Date: April 14 | Time & Location: 17:30 (Hall 3)

Cytomegalovirus

• Long-term safety and immunogenicity of cytomegalovirus mRNA-1647 vaccine in healthy adults: 36-month results from a phase 2 extension trial – Poster Presentation
  Presenter: Ben Lorenz
  Session: Clinical Trials
  Date: April 15 | Time & Location: 12:00 (Poster Hall)

Influenza

• Six-month persistence and safety of mRNA-based influenza or multicomponent influenza/COVID-19 vaccines versus licensed comparators in adults aged ≥18 years – Poster Presentation
  Presenter: Mieke Soens
  Session: Influenza and respiratory viruses
  Date: April 12 | Time & Location: 12:00 (Poster Hall)

Norovirus

• Incidence and severity of sporadic, medically attended norovirus infection in the United States, 2023-2024 - Poster Presentation
  Presenter: Mark A. Schmidt
  Session: Viral epidemiology – general, prevalence studies, molecular and genomic epidemiology
  Date: April 12 | Time & Location: 12:00 (Poster Hall)